Abstract: A computer implemented method for identifying records that deviate from a preferred prescribed course of care for a particular disease state includes receiving a transaction message including data related to a disease state and updating a database based on the received transaction message. Records related to a physician are identified within the updated database and records associated with a provider network are identified. A regional treatment plan for the disease state is determined based on the records related to the physician, and an impact record is generated based on the regional treatment plan for the disease state and the records associated with the provider network. Records that deviate from the preferred prescribed course of care are identified based on the impact record.

Abstract: A computer-implemented method includes receiving a treatment record descriptive of a pharmacy purchase transaction that includes a prescriber identification code and a pharmaceutical compound related to treatment for an individual disease state, and associating the received treatment record with a code indicative of a provider network. The treatment record is related to a time-based treatment record descriptive of a projected disease state for a specified treatment area and a treatment model is developed based on relating the received treatment record to the time-based treatment record. The treatment model indicates projected occurrences of the disease state over a specified time frame, the projected occurrences including a first code indicative of a prescribing authority, the treatment model also including an association label that identifies a linkage between treatment records with a threshold degree of similarity.

Abstract: The disclosure generally describes computer-implemented methods, software, and systems for measuring and quantifying the interactive effect of corporate parents and managed care organizations on pharmaceutical product performance. The disclosure relates to implementations that facilitate the accessing of information from actors within a health care system and processing the information by an analytical infrastructure.

Abstract: The disclosure generally describes computer-implemented methods, software, and systems for identifying the role of Integrated Delivery Networks (IDNs) in determining prescriber behavior, using an analytical and reporting infrastructure. The disclosure also describes determining a model role for the prescribing behavior of the prescribers affiliated with an IDN to establish a performance level of a drug.

Abstract: The disclosure generally describes computer-implemented methods, software, and systems for modeling the possible outcomes of a negative event in the market place. A negative event may be any event that has a negative impact on the marketshare value for a product in a territory. The disclosure also describes, presenting marketing investments that will reduce impact on the marketshare based on the occurrence of a negative event, by an analytical infrastructure.

Abstract: The disclosure generally describes computer-implemented methods, software, and systems for identifying the role of Integrated Delivery Networks (IDNs) in determining prescriber behavior. An IDN is a network of facilities and providers that work together to offer a continuum of care to a specific geographic area or market, and is a type of managed care organization. The disclosure relates to implementations that facilitate the accessing of information from actors within a health care system and processing the information by an analytical infrastructure.